drugset / Trial / NCT04774237

Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

NCT04774237

Phase 2 Completed 18 enrolled Visus Therapeutics
RandomizedCrossoverDouble-blindTreatment

Summary

Safety and Efficacy Study of BRIMOCHOL™ vs. BRIMOCHOL™ F vs. Carbachol Monotherapy Topical Ophthalmic Solutions in Subjects with Emmetropic Phakic and Pseudophakic Presbyopia

Timeline

Start
2021-03-24
Primary completion
2021-10-19
Completion
2021-10-19

Drugs

EvaluationDrugModalityDoseRoute
Subject BRIMOCHOL Unknown Topical
Subject BRIMOCHOL™ F Unknown Topical
Comparator CARBAMOYLCHOLINE Small molecule Topical

Indications